Annual Report 2023

Directors’ Report 董事會報告 121 舜宇光學科技（集團）有限公司 • 2023 年報 附註： 1. 計劃項下授出受限制股份的購買價為股份於各授 出日期在聯交所的收市價，即於二零二三年五 月二十二日為 81.70 港元、於二零二三年七月三 日為 79.05 港元及於二零二三年十一月二十日為 73.20 港元。 2. 於二零二三年五月十九日、二零二三年六月三十 日及二零二三年十一月十七日，緊接受限制股份 各授出日期前股份的收市價分別為 82.30 港元、 78.15 港元及 73.25 港元。 3. 緊接受限制股份歸屬日期前股份的加權平均收市 價為 86.98 港元。 4. 截至二零二三年十二月三十一日止年度，概無註 銷受限制股份。 5. 根據本集團的內部政策，該股份是指已授出予參 與者但尚未歸屬的股份。 6. 截至二零二三年十二月三十一日止年度，本集團 五名最高薪酬人士包括三名董事（即葉遼寧、孫 泱及王文鑒）及含僱員 A 在內的兩名僱員，該等 人士的酬金詳情已載於本年報綜合財務報表附註 14 。 7. 概無根據計劃發行股份，因此，就本財政年度內 根據計劃授出的受限制股份而可能發行的股份數 目除以截至二零二三年十二月三十一日止年度已 發行股份的加權平均數目的數據不適用於計劃。 除上文所披露者外，本公司或其附屬公司於年 內並無訂立任何安排，使董事或彼等各自的配 偶或未滿 18 歲的子女可透過收購本公司或任何 其他法團的股份或債券而獲取利益。 Notes: 1. The purchase price of the grant of Restricted Shares under the Scheme was the closing price of the Shares on the Stock Exchange on the respective grant date, i.e., HKD81.70 on 22 May 2023; HKD79.05 on 3 July 2023; and HKD73.20 on 20 November 2023. 2. The closing price of the Shares immediately before each of the grant date of the Restricted Shares was HKD82.30 on 19 May 2023; HKD78.15 on 30 June 2023 and HKD73.25 on 17 November 2023. 3. The weighted average closing price of the Shares immediately before the vesting date of the Restricted Shares was HKD86.98. 4. No Restricted Shares were cancelled for the year ended 31 December 2023. 5. According to the Group’s internal policy, the shares have been granted to the participants but not yet vested. 6. The five highest paid individuals of the Group included three Directors (i.e. Ye Liaoning, Sun Yang and Wang Wenjian) and two employees including Employee A for the year ended 31 December 2023. Details of their emoluments are set out in Note 14 to the consolidated financial statements in this annual report. 7. There was no issuance of Shares under the Scheme, and hence, the data concerning the number of Shares that may be issued in respect of the Restricted Shares granted under the Scheme during the financial year divided by the weighted average number of Shares in issue for the year ended 31 December 2023 is not applicable herein. Save as disclosed above, at no time during the year was the Company or its subsidiaries a party to any arrangement to enable the Directors or any of their spouses or children under 18 years of age to acquire benefits by means of the acquisition of Shares in or debentures of the Company or any other corporation.